Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongfei Fan

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Materials Today. Bio|December 9, 2025
Efficiently enhancing ferroptosis-mediated immunosensitization in lung cancer by an inhalable immune activation nanoplatformZhimin Chen, Yanze Yin, Changjie Yang, et al.
Journal of Inflammation Research|September 23, 2022
PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric CancerXinwei Li, Yongfei Fan, Mingyue Tang, et al.
Biomaterials|June 24, 2025
Regulation of cGAS-STING pathway with inhalable nanozyme in acute lung injuryXichun Qin, Zi Fu, Leilei Wu, et al.
Journal of Nanobiotechnology|September 5, 2024
Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapyKun Li, Leilei Wu, Han Wang, et al.
Frontiers in Genetics|May 16, 2022
<i>CHSY3</i> can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach AdenocarcinomaXinwei Li, Yongfei Fan, Yue Zhang, et al.
Nano-Micro Letters|January 11, 2026
Copper-Based Targeted Nanocatalytic Therapeutics for Non-Small Cell Lung CancerYongfei Fan, Jiao Chang, Xichun Qin, et al.
NPJ Digital Medicine|November 17, 2025
Tandospirone augments cisplatin treatment by lowering cholesterol and managing distress in NSCLC patientsXichun Qin, Bo Cheng, Shangshang Ma, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Materials Today. Bio|December 9, 2025
Efficiently enhancing ferroptosis-mediated immunosensitization in lung cancer by an inhalable immune activation nanoplatformZhimin Chen, Yanze Yin, Changjie Yang, et al.
Journal of Inflammation Research|September 23, 2022
PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric CancerXinwei Li, Yongfei Fan, Mingyue Tang, et al.
Biomaterials|June 24, 2025
Regulation of cGAS-STING pathway with inhalable nanozyme in acute lung injuryXichun Qin, Zi Fu, Leilei Wu, et al.
Journal of Nanobiotechnology|September 5, 2024
Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapyKun Li, Leilei Wu, Han Wang, et al.
Frontiers in Genetics|May 16, 2022
<i>CHSY3</i> can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach AdenocarcinomaXinwei Li, Yongfei Fan, Yue Zhang, et al.
Nano-Micro Letters|January 11, 2026
Copper-Based Targeted Nanocatalytic Therapeutics for Non-Small Cell Lung CancerYongfei Fan, Jiao Chang, Xichun Qin, et al.
NPJ Digital Medicine|November 17, 2025
Tandospirone augments cisplatin treatment by lowering cholesterol and managing distress in NSCLC patientsXichun Qin, Bo Cheng, Shangshang Ma, et al.
Pageof 3